Jennifer K. Schilling
Virginia Tech
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jennifer K. Schilling.
Pharmaceutical Biology | 2005
Gülaçtu Topçu; Ahmet C. Gören; Gökhan Bilsel; Mine Bilsel; Osman Çakmak; Jennifer K. Schilling; David G. I. Kingston
ABSTRACT The composition of the water-distilled essential oils of the berries and leaves of Juniperus excelsa. M. Bieb. were analyzed by gas chromatography-mass spectrometry (GC-MS). The main components in the berries of J. excelsa., accounting for 56.1% of the oil, were determined as α-pinene (34.0%), cedrol (12.3%), L-verbenol (5.4%), and D-verbenol (4.4%) while in the leaves of J. excelsa., accounting for 63.2% of the oil, were found to be α-pinen (29.7%), cedrol (25.3%), α-muurolene (4.4%), and 3-carene (3.8%). Cytotoxic and antimicrobial potential of the berries and leaves of J. excelsa. were investigated.
Pharmaceutical Biology | 2008
Gülaçtı Topçu; Zeynep Türkmen; Jennifer K. Schilling; David G. I. Kingston; John M. Pezzuto; Ayhan Ulubelen
Abstract Salvia hypargeia. Fisch. et Mey. (Lamiaceae) root extract, among 16 Salvia. extracts, showed the highest activity against the human ovarian cancer cell line. Bioactivity-guided fractionation of this plant extract has yielded four abietane-type diterpenes [5,6-didehydro-7-hydroxytaxodone (1), 14-deoxycoleon U (= 6-hydroxysalvinolone) (2), demethylcryptojaponol (3), and salvicanaric acid (4)] two triterpenes (lupeol and lupeol-3-acetate), and a fatty acid mixture consisting mainly of palmitic acid (51.6%) and palmitoleic acid (6.4%). Compounds 2 and 3 were found to be active against A2780 human ovarian cancer cell line with IC50 values of 3.9 and 1.2 μ g/mL, respectively, and the fatty acid composition was the most active part of the extract (IC50 = 0.6 μ g/mL).
Tetrahedron Letters | 2003
Changhui Liu; Markus Tamm; Marcus W. Nötzel; Armin de Meijere; Jennifer K. Schilling; David G. I. Kingston
Abstract Four paclitaxel analogs with a cyclopropanated side-chain were synthesized by coupling of the spirocyclopropanated oxazoline-5-carboxylic acid 4 with 7-TES-baccatin III, followed by hydrolytic ring opening and rearrangement. The absolute configuration of the 2′-position was determined by NMR analysis of the corresponding Mosher esters. The two new paclitaxel analogs with the R configuration at C-2′ were both active in the A2780 mammalian cell line cytotoxicity assay, but much less than paclitaxel itself.
Journal of Natural Products | 2002
V. S. Prakash Chaturvedula; Jennifer K. Schilling; David G. I. Kingston
Journal of Natural Products | 2004
Changhui Liu; Jeannine S. Strobl; Susan Bane; Jennifer K. Schilling; Meredith A. McCracken; Sabarni K. Chatterjee; Rayhana Rahim-Bata; David G. I. Kingston
Journal of Natural Products | 2003
V. S. Prakash Chaturvedula; Jennifer K. Schilling; James S. Miller; Rabodo Andriantsiferana; and Vincent E. Rasamison; David G. I. Kingston
Tetrahedron | 2003
Thota Ganesh; Jennifer K. Schilling; Radha K Palakodety; Rudravajhala Ravindra; Natasha Shanker; Susan Bane; David G. I. Kingston
Journal of Natural Products | 2002
V. S. Prakash Chaturvedula; Jennifer K. Schilling; James S. Miller; Rabodo Andriantsiferana; Vincent E. Rasamison; David G. I. Kingston
Planta Medica | 2003
V. S. Prakash Chaturvedula; Jennifer K. Schilling; James S. Miller; Rabodo Andriantsiferana; Vincent E. Rasamison; David G. I. Kingston
Journal of Natural Products | 2004
Gülaçtı Topçu; Zeynep Türkmen; Ayhan Ulubelen; Jennifer K. Schilling; David G. I. Kingston